John Ciallella, PhD
John is a Study Director at Charles River’s Safety Assessment site in Spencerville, Ohio. He joined the company in 2017 with nearly 20 years of experience in preclinical drug discovery and development in the pharmaceutical industry, focusing on CNS, metabolic, and inflammation areas. He currently oversees GLP and non-GLP toxicology studies in rodents, dogs, and swine. John received his PhD from the University of Kentucky where his research focused on the role of inflammation in Alzheimer’s disease. He also earned a BS in Marine Biology from Southampton College of Long Island University.